Everstone Invests $270M In Apothecon-Navinta Pharma Platform
14 Apr 2026 //
BUSINESS STD
Sandoz Initiates Renewable Energy Partnership
12 Aug 2025 //
INDPHARMAPOST
Sandoz delivers Strong H1 2025 Results
07 Aug 2025 //
GLOBENEWSWIRE
Sandoz reports Q1 2025 net sales in line with expectations
30 Apr 2025 //
GLOBENEWSWIRE
Shareholders approve all resolutions proposed by Sandoz Group AG
15 Apr 2025 //
GLOBENEWSWIRE
Sandoz issues bonds to repay loans and secures $2B credit
31 Mar 2025 //
GLOBENEWSWIRE
20 US states balk at Florida settlement with Sandoz
18 Mar 2025 //
REUTERS
Sandoz reports strong FY 2024 results and Q4 2024 sales
05 Mar 2025 //
GLOBENEWSWIRE
Avecho, Sandoz Partner To Develop CBD For Insomnia In Australia
03 Mar 2025 //
PR NEWSWIRE
Peter Stenico appointed President Region International
03 Feb 2025 //
GLOBENEWSWIRE
Sandoz To Strategic Roadmap At J.P. Morgan Health Conference
14 Jan 2025 //
GLOBENEWSWIRE
Intra-Cellular Settles Caplyta Patent Litigation with Sandoz
10 Jan 2025 //
GLOBENEWSWIRE
FDA updates label of 33-year-old cancer drug with dose & warning
21 Nov 2024 //
ENDPTS
FDA Updates Label Of 33-Year-Old Cancer Drug With Warning
20 Nov 2024 //
ENDPTS
Agomab Announces Appointment of Former Sandoz CFO
18 Nov 2024 //
BUSINESSWIRE
Sandoz reports third-quarter and nine-month 2024 sales
30 Oct 2024 //
GLOBENEWSWIRE
Sandoz And Liquidia Win $137M Against United In Remodulin Dispute
16 Sep 2024 //
FIERCE PHARMA
As Sandoz contract winds down, GSK will close antibiotics plant in UK
10 Sep 2024 //
FIERCE PHARMA
Regeneron takes on Sandoz over newly-approved Eylea copycat
29 Aug 2024 //
BLOOMBERG
Axsome Settles Sunosi Patent Litigation With Sandoz
21 Aug 2024 //
GLOBENEWSWIRE
Sandoz Gets FDA Approval For Enzeevu, Boosting US Biosimilar Position
12 Aug 2024 //
GLOBENEWSWIRE
Sandoz reports second-quarter sales and half-year 2024 results
08 Aug 2024 //
GLOBENEWSWIRE
Sandoz Launches Biosimilar Pyzchiva For Chronic Inflammatory Diseases
24 Jul 2024 //
GLOBENEWSWIRE
Sandoz’s Wyost and Jubbonti Granted EC Marketing Authorization
22 May 2024 //
GLOBENEWSWIRE
Sandoz reports first quarter 2024 sales
07 May 2024 //
GLOBENEWSWIRE
Sandoz reaches agreement with Amgen over patent dispute
01 May 2024 //
REUTERS
Sandoz AGM Approves All Board Proposed Resolutions
30 Apr 2024 //
GLOBENEWSWIRE
Bayer`s patent for blood thinner Xarelto invalid, UK court rules
13 Apr 2024 //
REUTERS
Sandoz opens new production facility in Austria for life-saving medicines
21 Mar 2024 //
GLOBENEWSWIRE
Sandoz reports fourth quarter 2023 sales and full-year 2023 results
13 Mar 2024 //
GLOBENEWSWIRE
Sandoz announces nominations to the Board of Directors and leadership change
05 Mar 2024 //
GLOBENEWSWIRE
Sandoz acquires CIMERLI® business from Coherus
04 Mar 2024 //
GLOBENEWSWIRE
Sandoz enters $265 mln settlement agreement in U.S. price-fixing case
29 Feb 2024 //
REUTERS
House Dems seek briefings with Pfizer, Sandoz and Teva on ongoing drug shortages
22 Feb 2024 //
ENDPTS
Sandoz to shutter Eon Labs site acquired nearly 20 years ago
09 Feb 2024 //
FIERCE PHARMA
Sandoz announces changes in the Board of Directors
01 Feb 2024 //
GLOBENEWSWIRE
Sandoz inaugurates new antibiotic production plant in Austria
10 Nov 2023 //
GLOBENEWSWIRE
Updated: Novartis `on track` to complete restructuring post Sandoz spin
24 Oct 2023 //
ENDPTS
Sandoz reports year-to-date sales for the first nine months of 2023
24 Oct 2023 //
GLOBENEWSWIRE
Novartis confirms Sandoz Spin-off for October 4, 2023
25 Sep 2023 //
GLOBENEWSWIRE
Sandoz publishes supplement to Listing Prospectus including Sandoz H1 2023
05 Sep 2023 //
GLOBENEWSWIRE
Merck looks to broaden Welireg`s reach in kidney cancer
19 Aug 2023 //
FIERCE PHARMA
Sanofi prevails over Sandoz in Jevtana patent case
30 Jun 2023 //
FIERCE PHARMA
Sandoz plans move to new central Basel headquarters by mid-2024
01 Jun 2023 //
GLOBENEWSWIRE
Sandoz to exclusively commercialize six products in the US
03 May 2023 //
GLOBENEWSWIRE
Sandoz must cough up $39M after losing Allergan patent fight
04 Apr 2023 //
FIERCE PHARMA
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit
03 Apr 2023 //
ENDPTS
Sandoz to expand its presence in Slovenia with new $400M plant
09 Mar 2023 //
ENDPTS
Novartis names Firmenich CEO as chairman designate of Sandoz
21 Feb 2023 //
REUTERS
Novartis delays Pluvicto filing after FDA requests more data
02 Feb 2023 //
FIERCE PHARMA
Novartis says operating profit to grow again ahead of Sandoz spin-off
01 Feb 2023 //
REUTERS
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives
25 Jan 2023 //
ENDPTS
Generic drugmakers Teva and Sandoz make major push to biosimilars
22 Nov 2022 //
REUTERS
FDA Warns Court Not To Side With Sandoz In Drug Challenge
08 Nov 2022 //
LAW360
Sandoz announces further investment in key manufacturing facility in Austria
08 Nov 2022 //
PRESS RELEASE
Novartis rolls out its third antibiotics boost in as many years
07 Nov 2022 //
FIERCEPHARMA
Under hub-and-spoke biotech, serial founders launch new startup gene therapies
31 Oct 2022 //
ENDPTS
No supply disruptions projected for Sandoz, Novartis CEO says
25 Oct 2022 //
FIERCEPHARMA
Hikma, Teva, Sandoz Report Short Supply of Amoxicillin in US
25 Oct 2022 //
BLOOMBERG
Sandoz Weighs In On US Adderall Shortages Amid Supply Disruption
11 Oct 2022 //
PHARMAINTELLIGENCE

Market Place
Sourcing Support